However, the weak p27 immunoreactivity suggests that it is expressed in low levels in all MYCN‐amplified tumors, except the RB1−/− tumor, UPEN‐RB‐201, where it is highly expressed in both well and poorly differentiated areas of the tumor (Fig. S1, I, and J). This evidence concerns the gene CDKN1B and neoplasm.